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The patho-physiological hypothesis of mental retardation caused by the deficiency of the RhoGAP
Oligophrenin1 (OPHN1), relies on the well-known functions of Rho GTPases on neuronal morphology, i.e.
dendritic spine structure. Here, we describe a new function of this Bin/Amphiphysin/Rvs domain containing
protein in the control of clathrin-mediated endocytosis (CME). Through interactions with Src homology
3 domain containing proteins involved in CME, OPHN1 is concentrated to endocytic sites where it down-
regulates the RhoA/ROCK signaling pathway and represses the inhibitory function of ROCK on endocytosis.
Indeed disruption of Ophn1 in mice reduces the endocytosis of synaptic vesicles and the post-synaptic a-
amino-3-hydroxy-5-methylisoazol-4-propionate (AMPA) receptor internalization, resulting in almost a com-
plete loss of long-term depression in the hippocampus. Finally, pharmacological inhibition of this pathway
by ROCK inhibitors fully rescued not only the CME deficit in OPHN1 null cells but also synaptic plasticity
in the hippocampus from Ophn1 null model. Altogether, we uncovered a new patho-physiological mechanism
for intellectual disabilities associated to mutations in RhoGTPases linked genes and also opened new
directions for therapeutic approaches of congenital mental retardation.
INTRODUCTION
X-linked mental retardation (XLMR) is a genetic disease
affecting mostly males. It is characterized by global cognitive
impairment and an intelligence quotient below 70 (1). To date,
82 genes have been implicated in XLMR, which display a
variety of clinical features. Traditionally, XLMR syndromes
have been characterized as either syndromic or non-syndromic
dependent on associated clinical abnormalities. Recent clinical
re-evaluation of some XLMR cases has, however, suggested
that the distinction may not be so clear-cut (2). The distinction
between syndromic or non-specific forms of MR is somehow
vanishing and some MR cases have been reconsidered
after clinical re-evaluation of patients. For example, the
non-specific MR gene mental retardation associated with
null mutations in Oligophrenin1 (OPHN1) was originally
described as non-syndromic (3), but later investigations
suggested a syndromic XLMR associated with cerebellar
hypoplasia and ventricular dilatation (4–6). We have recently
reported that the Ophn1 gene loss of function in mouse dis-
plays similarities to the human pathology, apart from the cer-
ebellar hypoplasia, results in dendritic spine immaturity and in
altered pre-synaptic function with a reduction of paired-pulse
facilitation in CA1 hippocampus (7). These defects may
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contribute to the spatial learning impairment in the animal
model and presumably to the cognitive deficit in patients
with mutations in the Oligophrenin1 gene. However, the func-
tion of OPHN1 and its possible involvement in a pathway reg-
ulating synaptic transmission is still largely unexplored; as is
the question whether the observed alterations in dendritic
spine morphology are a cause or consequence of abnormal
neurotransmission and/or synaptic activity (8,9).
In this study, we searched for new functions of OPHN1 using
a biochemical approach and found that it interacts with mol-
ecules involved in clathrin-mediated endocytosis (CME). We
next investigated this new function by studying the mouse
model of Ophn1 deficiency and found that various cellular
mechanisms mediated through CME are impaired in the
mutant. At the synapse, OPHN1 loss of function reduces both
the synaptic vesicle and a-amino-3-hydroxy-5-methylisoazol-
4-propionate (AMPA) receptor endocytosis affecting synaptic
plasticity. Finally, we showed that the RhoA/ROCK signaling
pathway is up-regulated in Ophn1 knock-out cells and that
pharmacological inhibition of this pathway restores not only
the CME deficits, but also the proper synaptic plasticity in
Ophn1 mouse model. In addition, these results highlight new
patho-physiological mechanisms for intellectual disabilities
associated to mutations in RhoGTPases linked genes.
RESULTS
OPHN1 interacts with three molecules involved
in CME: amphiphysins, endophilins and CIN85
Apart from the central RhoGAP domain, OPHN1 contains an
N-terminal Bin/Amphiphysin/Rvs (BAR) (10) domain fol-
lowed by a Pleckstrin homology domain and a C-terminal
domain with three proline-rich regions at amino acid positions
575, 629 and 740 with multiple Src homology 3 (SH3) binding
domains (Fig. 1A) (3,11). Using this latter region as bait in
the two-hybrid system, we screened a cDNA library from
fetal brain and found that amphiphysin II (12), endophilin
EENB1 and B2 proteins (13) and CIN85 (14) interact with
OPHN1 (Fig. 1A). As these proteins are known to participate
in different steps of CME (15–17), we explored this new
putative function of OPHN1. Previous studies have shown
that all four proteins are expressed in cortical neurons at
synaptophysin-positive synapses (11,15,18–22). We then per-
formed fractionation experiments in rat adult brain to test
whether OPHN1 is enriched in the same fractions as amphi-
physin I or II, Cin85 and endophilin. We found that the distri-
bution profile of OPHN1 in the pellet fractions is similar to
Cin85 and synaptophysin, a pre-synaptic protein attached to
synaptic vesicle membranes (Fig. 1B). As amphiphysin I and
II and endophilin were more enriched in the supernatant
fractions and only partially distributed with OPHN1, suggests
that their interactions with OPHN1 may not be constitutive
but regulated during endocytosis. We also investigated
the consequences of the loss of OPHN1 function on the
expression or fractionation pattern of these OPHN1-interact-
ing proteins using protein brain extract from Ophn1 null
mice (Ophn12/y) and found that they were not altered com-
pared with their wild-type littermates (Ophn1þ/y) (data not
shown). We next used glutathione S-transferase (GST) pull-
down experiments to confirm and study the OPHN1 inter-
actions. The SH3 domains of CIN85, amphiphysin II and
EEN-B1 were able to retain endogenous OPHN1 from adult
mouse brain extracts, whereas neither GST alone nor
GST-SH3 domain of bPIX, a Rac/Cdc42 exchange factor
known to interact with PAK3 (23), were able to bind to
OPHN1 (Fig. 1C). These results not only confirmed the inter-
actions but also showed the specificity of the SH3–
proline-rich domain interactions between OPHN1 and its part-
ners. Amino acid-sequence analyses of proline-rich motifs in
OPHN1 revealed the presence of two putative binding sites
for amphiphysin II (P/IXRPXR) at position 575 and 740,
one CIN85 binding site (PXXXPR) at position 575 and one
endophilin binding site (PPXRP) at position 740 (24,25). In
order to discriminate between the different proline-rich
binding sites of OPHN1, we expressed three enhanced green
fluorescent protein (EGFP)-fused proteins in COS cells corre-
sponding to either the whole C-terminal domain of OPHN1
(Cter) or parts of it, Cter A and B (Supplementary Material,
Fig. S1B) (11). Protein extracts from transfected COS cells
were incubated with various GST-purified SH3 domains
Figure 1. OPHN1 protein interactions with amphiphysins, endophilins and
CIN85. (A) Two-hybrid results from OPHN1 screening using the C-terminal
end (LexA-Cter). Black bars show overlapping cDNA clones recovered
from the two-hybrid screening (x): number of independent clones recovered
from the screening; in all cases, they include at least one SH3 site. BAR:
Bin/amphiphysin/Rvs, PH: Pleckstrin Homology, RhoGAP: Rho GTPase
activating protein, CC: coiled–coiled, P: proline-rich domains. (B) Rat brain
fractionation experiments showing the distribution of OPHN1 together with
its binding partners, amphiphysin I and II (Amphi I and II), CIN85 and endo-
philin. Synaptophysin and SNAP25 were used as positive control of fraction-
ation. Fractions as follows: S1, post-nuclear/cell soma; S2, supernatant; P2,
mitochondria and crude synaptosomes; S3, cytosolic; P3, microsomal/light
membrane compartment; LS1, soluble lysate; LP1, synaptosomal/presynaptic
plasma membrane; LS2, synaptosolic; LP2, enriched in SV and pre-synaptic
plasma membranes. (C) GST pull-down experiments. Purified GST-SH3
domains of CIN85 (ABC), amphiphysinII (AmphiII) or endophilin
(EENB1), but not the one from bPIX, are able to strongly bind to OPHN1
protein. Starting material (SM): protein extract at either 1 mg/ml (SM1) or
7 mg/ml (SM7). A 1 mg of protein extract was used for each pull-down exper-
iment; CS: Coomassie staining of SDS–PAGE gel is presented as loading
control.
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from amphiphysin I and II, CIN85 (three SH3 sites ABC) and
endophilins (EEN, EEN-B1 and EEN-B2) to test the relative
affinity of each EGFP-fused constructs of OPHN1. We
found that the first proline-rich region has overlapping
binding sites for CIN85 and amphiphysin II and the third
proline-rich region binds only endophilins (Fig. 1A and Sup-
plementary Material, Fig. S1A). Among the different partners
of OPHN1, amphiphysin I and II and endophilins contain only
one SH3 binding site at their C-terminal end, whereas CIN85
has three N-terminal sites A, B and C (Fig. 1A and Sup-
plementary Material, Fig. S1B). We tested in vitro various
combinations of GST-fused SH3 sites of CIN85 (constructs
A, B and C, Supplementary Material, Fig. S1B) for affinity
to OPHN1 CterA protein and found that all three SH3 sites
of CIN85 are potentially able to bind independently or in com-
bination to the first proline-rich site of OPHN1 (Supplemen-
tary Material, Fig. S1B). Taken together, these data show
that OPHN1 interacts with proteins implicated in CME via
proline–SH3 binding sites and suggest that OPHN1 plays,
through its interactions with these known adaptor molecules,
a functional role at endocytic sites.
Loss of OPHN1 leads to the activation of the RhoA/ROCK
signaling pathway and reduced receptor endocytosis in
various cell types
OPHN1 contains a central RhoGAP domain, which regulates
the RhoA/ROCK pathway (11,18). As this pathway has
been shown to modulate the receptors endocytosis through
endophilin phosphorylation and interaction with CIN85
(26,27), we examined the level of its activation in Ophn12/y
cells. We first studied the activation kinetics of RhoA in
serum-stimulated fibroblasts, which results in robust activation
of RhoA. Using GST pull-down experiments, we found
that total RhoA activity is approximately doubled in Ophn12/
y compared with Ophn1þ/y (Supplementary Material,
Fig. S2A). We next looked at the activity of the RhoA effector
ROCK through quantification of phosphorylation status of one
of its substrate, the myosin-binding subunit (MYPT1) of the
myosin phosphatase in astroglial cells (28). Ophn12/y cells pre-
sented a significant increase of MYPT1 phosphorylation (1.4)
compared with Ophn1þ/y (Supplementary Material, Fig. S2B;
Ophn1þ/y: 0.45+0.05; Ophn12/y: 0.64+0.11; P, 0.05,
Mann–Whitney test (MW), n ¼ 4); a phenotype, which could
be completely abolished by pre-incubation of the cells with
the ROCK inhibitor Fasudil (Supplementary Material,
Fig. S2B). These results demonstrated that loss of function of
OPHN1 increases the activation of the RhoA/ROCK pathway.
To directly test the consequences of this activation on
CME, we performed endocytic assays on primary astroglial
cells from both genotypes using fluorescent-labeled transferrin
(Tf) or epidermal growth factor (EGF) as tracer of constitutive
or inducible CME of their respective receptors (Supplementary
Material, Fig. S2C). Using FACS analysis, we found that
Ophn12/y cells have a reduced constitutive internalization
rate (64%) compared with Ophn1þ/y (Supplementary Material,
Fig. S2C; Ophn1þ/y: 87+ 11; Ophn12/y: 31+ 4, P , 0.01
two-tailed Student’s t-test n ¼ 4). A similar decrease in EGF
receptor internalization was observed in Ophn12/y fibroblasts
using cell-image analyses (data not shown). We next used
a specific inhibitor of ROCK, Y27632 (29) to test whether
incubation of Ophn12/y astroglial cells with this drug could
abolish the CME deficit. Treatment with Y27632 did not signifi-
cantly alter endocytosis in Ophn1þ/y cells (Supplementary
Material, Fig. S2C; Ophn1þ/y (2)Y27632: 87+ 11;
Ophn1þ/y (þ)Y27632: 74+ 7). This result confirms previous
studies showing that ROCK inhibition has no effect on endocy-
tosis in basal conditions (26,30). In contrast, treatment with
Y27632 fully rescued the defect inOphn12/y cells (Supplemen-
tary Material, Fig. S2C; Ophn12/y (2)Y27632: 31+ 4;
Ophn12/y (þ)Y27632: 84+ 8; P , 0.01 two-tailed Student’s
t-test, n ¼ 4). Thus the activation of the RhoA/ROCK signaling
pathway secondary to OPHN1 loss of function is responsible
for the reduction of CME in astroglial cells.
Synaptic vesicle endocytosis are reduced
in cortical neurons
Since removal of amphiphysins from mouse brain led to some
defects in the synaptic vesicles endocytosis (SVE) (31), we
tested whether Ophn1 null mice displayed a similar deficit.
Using purified synaptosomes from Ophn1þ/y and Ophn12/y
mice cortices, we compared the exocytotic and recycling effi-
ciency of synaptic vesicles (SV). High potassium-evoked gluta-
mate release was unaffected in Ophn12/y synaptosomes (7.1+
0.6 versus 6.5+ 2.1 nmol/mg, P ¼ 0.6, two-tailed Student’s
t-test, n ¼ 3). We next employed the fluorescent amphipathic
styryl dye, FM2-10, to study the recycling of SV after two suc-
cessive depolarization steps by high potassium concentration
(32). Using Ca2þ or EGTA containing buffers for unloading
steps, we calculated an index called retrieval efficiency (33)
to allow direct comparison of recycling between genotypes
(Fig. 2A, left panel). We found that the Ca2þ-dependant retrie-
val efficiency was decreased by 17% in Ophn12/y (Fig. 2A,
right panel, Ophn1þ/y: 1.82+ 0.02; Ophn12/y: 1.42+ 0.01;
P , 0.03, two-tailed Student’s t-test, n ¼ 4). Since the
release of glutamate was normal, we hypothesized that
Ophn12/y synapses would have a deficit in the synaptic
vesicle endocytosis/recycling. We subsequently used a cellular
model to study the uptake of another fluorescent amphipathic
styryl dye, the FM1-43, in individual synapses from cortical
neurons after potassium stimulation (34). Whereas there was
no effect on synaptic density as measured by the density of
the pre-synaptic marker synaptophysin (Ophn1þ/y: 385+ 97;
Ophn12/y: 402+ 122; P, 0.13, MW test, n ¼ 3), we found
that loss of OPHN1 function reduces the density of FM1-43
puncta (228%) co-localized with synaptophysin (Fig. 2B;
Ophn1þ/y: 217+ 95; Ophn12/y: 157+ 56; P , 0.02, MW
test, n ¼ 3). We also analyzed the internalization of synaptotag-
min1 as a marker of SV, which undergoes recycling between
the pool of SV and pre-synaptic membranes during exocytosis
and endocytosis (35). First we determined that the expression
of synaptotagmin1 was not affected in Ophn12/y and that it
co-localized with the pre-synaptic markers vesicular glutamate
transporter-1 (VGluT-1) during resting conditions (data not
shown). We then quantified synaptotagmin1 antibody uptake
in Ophn1þ/y and Ophn12/y neurons (Fig. 2C) after stimulation
by high potassium and found that the number of synaptotag-
min1 positive synapses is decreased in Ophn12/y cells
(229%) confirming the FM1-43 results (Fig. 2C; Ophn1þ/y:
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411+ 127; Ophn12/y: 291+ 92; P , 0.02, MW test, n ¼ 3).
In conclusion, we showed that loss of OPHN1 function
reduces the uptake and internalization of various tracers in
different models suggesting that OPHN1 contributes to the
regulation of a pathway controlling synaptic vesicle endocyto-
sis in a significant fraction of synapses.
Loss of OPHN1 affects AMPA receptor endocytosis
and synaptic plasticity in the hippocampus
In addition to its localization in the pre-synaptic compartment,
OPHN1 is also present at the post-synaptic site (7,11,18),
where it could regulate the recycling of various receptors includ-
ing the AMPA receptors (AMPARs) (36). Translocation of
AMPARs from cell surface to intracellular compartments in
Ophn1þ/y and Ophn12/y neurons was visualized and quantified
by an ‘antibody feeding’ immunofluorescence internalization
assay. In Ophn1þ/y neurons, the basal endocytosis of GluR1
subunit was rapid, reaching a maximum degree in 5 min
without reaching a plateau (Fig. 3A and B and Supplementary
Material, Fig. S3). In contrast, in Ophn12/y neurons, GluR1
subunit endocytosis was significantly down-regulated (Fig. 3A
and B and Supplementary Material, Fig. S3), suggesting that
OPHN1 contributes in the mechanism controlling the
AMPARs trafficking.
Interestingly, this effect was selective of GLUR1 subunit,
since GLUR2 internalization rate was not affected by the
loss of OPHN1 function (Supplementary Material, Fig. S3).
Current theories suggest that N-methyl-D-aspartic acid
(NMDA)-dependent long-term depression (LTD) is a result of
AMPAR internalization at the post-synaptic membrane (37,38)
via CME (36,39,40). As Ophn12/y mice display reduced
AMPAR internalization in neurons, we hypothesized that LTD
may be altered in Ophn12/y mice. We therefore examined
NMDA-dependent LTD at the CA3:CA1 synapse using the
extracellular recording technique (Supplementary Material,
Fig. S4Bi and Bii). Synaptic responses were recorded in the
stratum radiatum of the CA1 region of the hippocampus, and
were evoked by stimulation of the Schaffer collateral. Repetitive
stimulation at low-frequency (900 pulses, 1 Hz) depressed
synaptic responses in Ophn1þ/y slices (0.70+0.05, n ¼ 14,
P, 0.001, Fig. 4A and Bi), but not Ophn12/y slices (0.94+
0.06, n ¼ 11, P ¼ 0.66, Fig. 4A and Bi). As the reduction in
CME in Ophn12/y astroglial cells was rescued by treatment
with the Y27632 ROCK inhibitor (Fig. 3C), we examined
whether the observed deficit in the NMDA-dependent LTD
was similarly reversed. Y27632 (10 mM) was added to the circu-
lating artificial cerebrospinal fluid (aCSF) for 25 min before, and
throughout the LTD protocol and did not alter population synap-
tic potentials (PSP) amplitude (Supplementary Material,
Fig. S4Ai and Aii). In Y27632-treated Ophn1þ/y slices, low
frequency repetitive stimulation produced LTD (0.62+0.08,
n ¼ 5, P, 0.01, Fig. 4Bii), the magnitude of which did not
differ from untreated slices (P ¼ 0.61). In contrast, in
Ophn12/y slices, Y27632 revealed that repetitive stimulation
Figure 2. Reduced synaptic vesicle recycling and uptake in synaptosomes and
neurons from Ophn12/y. (A) Decreases of fluorescence were measured from
FM2-10-labeled synaptosomes using different unloading conditions of Ca2þ
(Ca/Ca or Ca/EGTA). A ratio, called retrieval efficiency (RE) was calculated
at 300 s for both genotypes. Synaptosomes from Ophn12/y (RE¼1.48+0.06)
showed a reduced RE (17%) compared with Ophn1þ/y (RE ¼ 1.78+0.15)
(P ¼ 0.03, two-tailed Student’s t-test, n ¼ 4). (B) Neurons were stimulated
by high potassium buffer in the presence of FM1-43 dye. Only FM1-43
punctae (in green) co-localized with the pre-synaptic protein synaptophysin
(Syn, in red) were quantified (FM1-43þ). Ophn12/y neurons (157+48) pre-
sented a 28% reduction in FM1-43 compared with Ophn1þ/y (217+86)(P ,
0.02, Mann–Whitney test, n ¼ 3). (C) For synaptotagmin1 antibody uptake
experiments, neurons were stimulated in the presence of an antibody directed
against the luminal domain (SytLum in green). The cells were fixed, permea-
bilized and stained with a second antibody against cytoplasmic domain
(SytCyt in red). Ophn12/y neurons (291+92) presented a 29% reduction in
synaptotagmin1 antibody uptake compared to Ophn1þ/y (411+127) (P,
0.02, Mann–Whitney test, n ¼ 2).
Figure 3. Reduced AMPA receptor endocytosis in Ophn12/y ippocampal
neurons endocytosis of GluR1 subunit was visualized and quantified by the
immunofluorescence internalization assay as indicated. Pre-labeled AMPA
receptors remaining on the surface are in green, internalized receptors in red
(see Materials and Methods). Basal GluR1 subunit internalization at 5 min
in Ophn1þ/y and Ophn12/y neurons is shown in (A). The quantitation of
time course of basal GluR1 subunit internalization in Ophn1þ/y and
Ophn12/y neurons, measured as the ratio of internalized (red)/total (red þ
green) fluorescence, normalized to control (total¼100) is shown in (B). In
Ophn12/y neurons GluR1 subunit endocytosis was significantly down-
regulated.
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induced LTD (0.64+0.03, n ¼ 5, P, 0.005, Fig. 4Bii), which
significantly differed from untreated slices (P, 0.001). These
data therefore support the hypothesis that OPHN1may also func-
tion as a regulator of AMPAR internalization via a ROCK-
dependent mechanism of CME.
DISCUSSION
Using biochemical and physiological approaches, we ident-
ified a new function of OPHN1 in CME through the regulation
of Rho GTPase signaling pathways. F-actin bound OPHN1
(11) is recruited to endocytic sites by SH3–proline inter-
actions with three known adaptor molecules involved in
CME: endophilin, amphiphysin and CIN85. We have pre-
viously shown that the N-terminal end of OPHN1 containing
the BAR domain negatively regulates the RhoGAP activity
(11). Locally, the increase in OPHN1 concentration would
favor its homo-dimerization and/or binding to curved mem-
branes and its RhoGAP activity would be activated by either
a change in its conformation or by an alternative unknown
mechanism (41). Activated OPHN1 negatively regulates the
RhoA/ROCK pathway, repressing the inhibition of this
pathway on CME (Supplementary Material, Fig. S5). This
effect could be direct through endophilin phosphorylation by
ROCK and consecutive inhibition of CIN85 interaction with
endophilin as shown by Kaneko et al. (26). As endophilin con-
centrates OPHN1 to endocytic sites, this would suggest the
existence of a negative retrocontrol loop of endophilin on
RhoA/ROCK inhibition. Alternatively or in combination
with this mechanism, other activities of ROCK effectors
such as myosin light chain kinase (42) may be regulated to
remodel the actin cytoskeleton during endocytosis.
At the synapse, the differences in synaptosome vesicle
cycling between Ophn1þ/y and Ophn12/y suggest deficits in
pre-synaptic function. In line with these findings, we previously
showed that Ophn12/y exhibits an impairment in paired-pulse
facilitation measured in CA1 hippocampus that could result
either from an increase of release probability, a reduction of
build-up Ca2þ or a slower rate of SV recycling mechanism (7).
In addition to synaptosome and cellular studies using
exogenous and endogenous tracers, impairment in SV
cycling was reinforced by electrophysiological studies that
showed are a deficit in the size of the pool of readily releasable
vesicles together with slower vesicle recycling at the perforant
path/dentate gyrus synapses (Powell et al., submitted for pub-
lication). These synaptic transmission abnormalities in
Ophn12/y were also rescued by superfusion of hippocampal
slices with Y27632 ROCK inhibitor (Powell et al., submitted
for publication).
Efficient recycling of SV is required to sustain the high-
frequency synaptic transmission observed at synapses, and to
maintain structural and functional integrity of the SV pools
and presynaptic membrane compartments. Multiple mechan-
isms of SV recycling have been proposed (43). Direct endocy-
tosis through a clathrin-mediated mechanism account for most
of SV recycling under normal and sustained conditions as
demonstrated recently by removal of clathrin which severely
perturbed SVE in rodent CNS synapses (44).
The efficiency of the SV recycling machinery is important in
the formation of a robust memory under challenging conditions.
The different SV pools are required for efficient synaptic trans-
mission and short-term memory formation and processing.
The GDI1 gene, responsible in human for X-linked non-
specific mental retardation, encodes a-GDI, a regulatory
protein common to the Rab GTPases family. In mouse, lack
of Rab-GDI perturbed the functionality of different SV pools
at the presynaptic site. The reduction in SV did not alter long-
term potentiation (LTP) following theta-burst tetanus in the
CA1 region of the hippocampus but, as expected, was associ-
ated to a decrease in Post-tetanic-potentiation and a delayed
recovery of synaptic transmission after depression (45).
In addition to its function in SVE, OPHN1 regulates the
endocytosis of AMPARs at the post-synaptic site. Similarly
to Arc/Arg3.1 (46,47), OPHN1 loss of function leads to a
selective reduction of GLUR1 internalization, whereas the
GLUR2 subunit is not affected. The AMPAR internalization
experiments were performed in the absence of TTX (Tetrodo-
toxin). Therefore, in the used conditions of neuronal cell
culture, the measured rates of AMPARs correspond to
activity-dependant synaptic responses plus constitutive rate
of internalization. Previous physiological studies (7) showed
no difference in (S)-3,5-dihydroxyphenylglycine (DHPG)-
induced LTD measured in CA1 hippocampus suggesting that
mGluR-dependent AMPAR internalization is not affected by
ophn1 loss of function. However, LFS-induced LTD, which
is NMDA dependent, is severely impaired in OPHN1 KO.
Altogether, these results from cellular and physiological
studies suggest that activity-induced internalization of
AMPAR is reduced in the ophn1 KO, affecting the GLUR1
subunit but not GLUR2. Previous studies have shown that in
Figure 4. Long-term depression (LTD) is reduced in Ophn12/y hippocampal
slices. (A) Population synaptic responses recorded from the stratum radiatum
of CA1, before (†) and after (‡) induction of LTD in Ophn1þ/y (left panel) and
Ophn12/y slices (right panel). LTD was induced by repetitive stimulation (900
pulses, 1 Hz) of the Schaffer collaterals. (Bi) LTD was reduced in Ophn12/y
slices (white circles) compared with Ophn1þ/y slices (dark circles). Inhibition
of ROCK by superfusion of Y-27632 (10 mM) resulted in LTD being observed
in Ophn12/y slices (Bii, light gray column), but did not alter expression of
LTD in Ophn1þ/y slices (Bii, dark gray column). The degree of induction of
LTD was taken as the mean normalized PSP (population synaptic potential)
slope between 40 and 45 min post-induction protocol. (Bii) To evaluate
whether LTD was induced, a one sample Student’s t-test was used (Null
hypothesis value was 1. P , 0.001, P, 0.005 and P , 0.01). Compari-
sons between control and drug-treated slices were performed using an inde-
pendent samples t-test (###P, 0.001). The significance value in all tests
was set as 0.01, to allow for multiple comparisons.
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mature hippocampal pyramidal cells, AMPARs occur predo-
minantly as complexes containing GluR1/2 or GluR2/3 (48).
The current model of AMPAR trafficking suggests that
AMPARs containing GluR1 are inserted into synapses in an
activity-dependent manner, whereas GluR2/3 heteromers
cycle constitutively into and out of synapses (49). Since
both subunits are internalized through CME, this would
suggest that either OPHN1 controls the selective endocytosis
of GLUR1 homomers or loss of OPHN1 function leads to sec-
ondary changes of the AMPAR subunit composition with a
shift toward more GLUR2-lacking AMPARs. Alternatively,
the selectivity for a pool of AMPAR may depend on the rate
at which the receptors cycle into and out of the synapse (50).
What could be the physiological consequences of these
changes? We have previously reported that LTP and
mGLUR1-dependant LTD were not modified in the
Ophn12/y hippocampus (7). Here we found that NMDAR-
dependant LTD is barely induced by low-frequency stimu-
lation. Although both forms of LTD are mediated by the
endocytosis of AMPAR, the signaling cascades that support
each LTD are distinct. For instance, DHPG (mGLUR1
agonist)-stimulated LTD involved the local synthesis of Arc/
Arg3.1 protein that binds to endophilins and dynamin,
promoting AMPAR endocytosis (51,52). We can speculate
that either OPHN1 is not involved in the cascade mediating
mGLUR1-LTD or that Arc/Arg3.1 compensate for OPHN1
deficiency for this specific form of LTD.
Taken together, these compelling results suggest that part of
the intellectual disability in OPHN1 patients is a consequence
of abnormal synaptic transmission linked to enhanced RhoA/
ROCK activation and reduced endocytosis. Thus it might be
possible to correct this deficit by reducing Rho GTPase signal-
ing via inhibition of Rho-kinases. Consistent with this possi-
bility, we found that blockade of Rho-kinases using the
selective antagonist Y27632 could not only correct the
decreased CME in cultured cells from Ophn12/y mice, but
also restore synaptic transmission and plasticity in Ophn12/y
hippocampal neurons. An exciting implication of this discov-
ery is that drugs targeting Rho-kinases or others Rho GTPases
effectors might be therapeutically useful for Rho GTPases
linked mental retardations, assuming that they share a
common patho-physiological mechanism.
MATERIALS AND METHODS
Primary cell culture and animals
Experimental procedures were performed in accordance with
the European Communities Council Directive (86/809/EEC)
regarding the care and use of animals and were approved by
the local Ethics Committee. Cortical neurons, fibroblasts and
astroglial cells from Ophn1 knock-out animals and wild-type
controls in C57BL/6 background were prepared by standard
procedures as previously described (7).
Two-hybrid screening
A fetal brain matchmaker cDNA library (Cat# HL4028AH,
lot# 7110056 from Clontech CA, USA) was screened with
a bait consisting of the human OPHN1 cDNA BglII/SalI
fragment (amino acid 563–802) in VJL9 vector derived
from pBTM116 (LexA binding domain); the yeast strain
L40 (53) was maintained according to standard protocols
(54). Out of 50 recovered cDNA clones from 1 million
screened, 22 corresponded to amphiphysin II, 10 clones to
endophilin genes (EEN-B1 and B2), and two clones to
CIN85 protein.
GST pull-down
GST-tagged SH3 proteins were expressed in BL21 bacterial
cells (Promega, WI, USA) and affinity purified according to
standard protocols (55). Cos-1 cells were transfected using
Lipofectamine (Invitrogen, CA, USA) with the following con-
structs: GFP-Cter, BglII/SalI (amino acid 563–802) in
pEGFP-CD11 (Clontech),GFP-Cter A BglII/PstI (amino acid
563–677) in pEGFP-CD11,GFP-Cter B PstI/SalI (amino
acid 677–802) in pEGFP-C3 (Clontech). Transfected proteins
were detected with anti-GFP monoclonal antibody.
RhoA and ROCK activation assay
RhoA activation assay was performed starting from fibroblasts
cell extracts according to manufacturer‘s instructions
(Cytoskeleton, CO, USA).
Rho-kinase activity was quantified by MYPT1 phosphoryl-
ation on Thr-853 by western blot analyses starting from astro-
glial cells protein extracts. The ratio of phospho-MYPT1
against total MYPT1 density was calculated after quantifi-
cation using densitometric analysis with ImageJ software.
Brain fractionation and preparation of synaptosomes
Rat brain from one adult male was processed according to pro-
tocols from (56), 75 mg of proteins were loaded on 5–15%
gradient SDS–PAGE gel for western blot experiment. Synap-
tosomes from five to seven cerebral cortices of adult mice
were prepared by centrifugation on discontinuous percoll gra-
dients as previously described (32,57).
Glutamate exocytosis and content
The glutamate release was performed by enzymatic assay
using the glutamate dehydrogenase as previously described
using 1 mg of purified synaptosomes (58). The total glutamate
content of 0.5 mg purified synaptosomes was determined after
complete lysis and extraction in 0.1% Triton by the same
method described above. The fluorescence intensities were
acquired using a thermostated Cary Eclipse fluorescence spec-
trophotometer (Varian, CA, USA).
Synaptosome FM2-10 recycling
Two milligram of purified synaptosomes was loaded at 378C
with 100 mM FM2-10 (Molecular Probes, OR, USA) by
depolarization with 30 mM KCl for 90 s in the presence of
1.3 mM Ca2þ as previously described (32,57). After two
washes in low Kþ saline solution with 1 mg/ml BSA, 1 mg
of labeled synaptosomes were unloaded by a second 30 mM
KCl induced depolarization in the presence of 1.3 mM Ca2þ
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or 2 mM EGTA. Depending of the presence of Ca2þ
(Ca2þCa2þ or Ca2þEGTA), we obtained two values of fluor-
escence that allowed us to calculate an index called retrieval
efficiency [RE ¼ CaCa/(CaCa–CaEGTA)] (33). By dividing
the amount of endocytosis by exocytosis, this ratio bypasses
the variability linked to synaptosomal purification and
allowed us to quantitatively compare independent preparations
from both genotypes.
FM1-43 uptake in cultured neurons
Synapses from individual cortical neurons were labeled with
FM1-43 (Molecular Probes) according to Mozhayeva et al.
(59). Neurons were then washed in a Tyrode buffer for
10 min and fixed in 4% paraformaldehyde/0.2% glutaralde-
hyde in PBS for 10 min. After fixation, cells were incubated
with VGluT-1 or synaptophysin antibodies for detection of
all synapses. Thirty-five neurons from each genotype were
acquired with identical imaging conditions and analyzed simi-
larly. Analyses were performed by quantification of the
number of FM1-43 punctae co-localized with synaptophysin
and normalized to the neuron surface. The experiment was
repeated three times with similar results.
Synaptotagmin uptake in cultured neurons
Endocytosis of synaptotagmin1 antibody at steady state or
after potassium-induced exocytosis was tested according to
Takei et al. (35). Briefly, neurons were incubated at 378C
for 30 min with SytLum–Abs (SynSyst antibody) mouse
monoclonal antibody, directed to the luminal domain of
synaptotagmin and stimulated with 90 mM KCl for 2 min.
Neurons were then washed and fixed before staining for
synaptotagmin cytoplasmic domain antibody (SynSyst),
rabbit polyclonal antibody to visualize the total of synaptotag-
min vesicles pool. Twenty neurons from each genotype were
acquired with identical imaging conditions and analyzed simi-
larly. Positive synapses for SytLum antibody were normalized
to the neuron surface. The experiment was repeated twice with
similar results.
EGF and Tf uptake
Receptor-mediated endocytosis was analyzed by assays for
EGF and Tf uptake as previously described (60). Adherent
cells (fibroblasts or astroglial) were incubated with 15 mg/ml
FITC-labeled Tf for 10 min at 378C. Labeled cells were
washed and re-suspended in medium after trypsin application
and immediately put on ice for FACS analysis.
For rescue assays, cells were serum starved during 2 h in
presence of 10 mM Y27632 (Sigma, MO, USA) (29) before
incubation with labeled transferring. Flow cytometry measure-
ments of at least 5000–10 000 cells per sample were analyzed
using Cellquest software on a FACSCalibur (BD Biosciences,
CA, USA). Fluorescent values from untreated Ophn1þ/y are
set to 100 and other conditions are expressed as percentage
of Tf receptor uptake normalized to untreated Ophn1þ/y.
AMPAR internalization assay
Live hippocampal neurons at 15–18 days in vitro were labeled
for 10 min at 378C with an antibody directed against the extra-
cellular region of either GluR1 or GluR2. After washing in
PBS, 1 mM MgCl2 and 0.1 mM CaCl2 (PBSþMC), neurons
were incubated at 378C in conditioned growth medium for
different times (0, 5, 10, 15, 20 min). Neurons were fixed
for 5 min at room temperature in 4% paraformaldehyde/4%
sucrose without permeabilization, and stained with FITC con-
jugated secondary antibodies for 1 h at room temperature, to
visualize pre-labeled surface receptors. Neurons were then
permeabilized for 1 min in 100% methanol at 2208C and
stained with Cy3-conjugated secondary antibodies for 1 h at
room temperature in GDB buffer (permeabilizing conditions:
30 mM phosphate buffer pH 7.4 containing 0.2% gelatin,
0.5% Triton X-100 and 0.8 M NaCl), to visualize pre-labeled
internalized receptors. Red fluorescence average intensities
indicative of internalization were divided by total average
(red þ green) fluorescence intensities to control (time 0) for
synaptic density.
Image acquisition and analysis
Fluorescence images were acquired using a coolSnap digital
camera (Roper Scientific) or a Photometrics CCD camera
(Princeton Instruments, Trenton, NJ, USA). Acquired image
sequences were saved as stacks of 16 bit TIFF files and ana-
lyzed with ImageJ software (http://rsb.info.nih.gov/ij/) or
Metamorph software (Universal Imaging Corporation, West
Chester, PA, USA).
Antibodies
The following primary antibodies were used: amphiphysins
and endophilins kindly provided by Pietro Camilli, CIN85
(cat#231006 from Calbiochem, Darmstadt, Germany),
PAK3 (cat#SC1871-N19 from Santa Cruz, CA, USA), OPHN1
(cat#SC8374-C19 Santa Cruz), GFP (cat#1814460 from
Roche, Mannheim, Germany), Synaptophysin (cat#VAM-
SV011 from StressGen, Canada), SNAP25 (cat#VAM-SV012
from StressGen, Canada), VGluT-1 kindly provided by S. El
Mestikawy and B. Giros, GFAP (cat# sc-6170 from Santa
Cruz), Tubulin (cat# T 6074 from Sigma), anti-MYPT1 antibody
(cat#990407 from Upstate, NY, USA) and antiphospho-MYPT1
Thr853 (cat#36-003 from Upstate), GluR1 (Oncogene Research
Products, Cambridge, MA, USA) or GluR2 (Chemicon Inter-
national, Temecula, CA, USA). Fluorescent-conjugated
secondary antibodies were purchased from Jackson Immuno-
Research Labs, (West Grove, USA).
Electrophysiology
Mice were anaesthetized by intraperitoneal injection of a
mixture of medetomide (1 mg/kg) and ketamine (76 mg/kg)
prior to being killed by cervical dislocation, their brains
removed for preparation of 400 mm ventral slices of the
dorsal hippocampus slices using a Vibroslice (Campden
Instruments, Loughborough, UK). Slices were placed in an
interface recording chamber perfused with aCSF containing
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(in mM): 125 NaCl, 26 NaHCO3, 1.25 NaH2PO4, 3 KCl, 2
CaCl2, 1 MgCl2 and 10 Glucose, pH 7.4., gassed with 95%
O2, 5% CO2, maintained at 328C. Slices were allowed to
recover for a period of 1 h prior to recording.
Stimuli were applied through a concentric stimulating elec-
trode (Harvard Apparatus, Edenbridge, UK) placed in the
stratum radiatum 150 mm from the CA1 pyramidal cell
layer. Recordings of PSP were made from the same layer of
stratum radiatum, 2 mm away, using glass microelectrodes,
an Neurolog DC amplifier and a 1401plus signal acquisition
system running Signal version 3.10 (Cambridge Electronic
Design, Cambridge, UK). Stimulus response curves used a
fixed set of stimulus strengths and the field PSPs were
measured as the slope (between 20 and 80% of maximum.
LTD was induced by 900 stimuli delivered at 1 Hz after at
least 15 min of recording half maximal stimuli delivered
every 60 s. The same test stimuli were then delivered for a
further 45 min.
Statistical analyses
Microsoft Excel (Microsoft) with StatEL plugin from
AdScience (France) was used for statistical analyses. All
results are given as mean+SEM unless otherwise stated.
All probability values are given for an alpha level of 5%
using MW as non-parametric test or two-tailed, unpaired Stu-
dent’s t-tests for analyses of data from synaptosomes.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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